
BrainsWay is dedicated to developing and providing advanced technology solutions for the treatment of a variety of brain disorders. The company was established in 2003, and became a public company traded on the Tel-Aviv Stock Exchange in January 2007. BrainsWay's flagship technology is Deep-TMS, or ... BrainsWay is dedicated to developing and providing advanced technology solutions for the treatment of a variety of brain disorders. The company was established in 2003, and became a public company traded on the Tel-Aviv Stock Exchange in January 2007. BrainsWay's flagship technology is Deep-TMS, or Deep Transcranial Magnetic Stimulation, which launches a new era in brain disorder treatment. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 5.79 | 5.79 | 5.79 | 2300 | 5.79 | CS |
12 | 0.9526 | 19.6923967421 | 4.8374 | 5.79 | 4.8374 | 2867 | 5.34693023 | CS |
26 | 2.64 | 83.8095238095 | 3.15 | 8.525 | 3.15 | 1558 | 5.31442246 | CS |
52 | 3.94 | 212.972972973 | 1.85 | 8.525 | 1.85 | 1315 | 3.77528363 | CS |
156 | 1.79 | 44.75 | 4 | 8.525 | 0.011 | 1478 | 2.25726093 | CS |
260 | 2.29 | 65.4285714286 | 3.5 | 8.525 | 0.011 | 1198 | 2.59853239 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales